Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A consensus platform for antibody characterization.

Nature protocols·2024
Same author

The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1.

British journal of pharmacology·2022
Same author

Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease.

Neurodegenerative disease management·2022
Same author

Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility.

Scientific reports·2022
Same author

Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing.

Scientific reports·2022
Same author

Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission.

Nature communications·2022

Related Experiment Video

Updated: Apr 20, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

29.4K

Genome engineering using Adeno-Associated Virus (AAV).

Rob Howes1, Christine Schofield

  • 1MedImmune, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK, howesr@medimmune.com.

Methods in Molecular Biology (Clifton, N.J.)
|November 20, 2014
PubMed
Summary
This summary is machine-generated.

Adeno-Associated Virus (AAV) gene editing creates precise genetic modifications in cell lines. This method generates over 500 human isogenic cell lines for studying gene function and disease biology.

More Related Videos

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain
09:59

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

Published on: March 31, 2022

3.4K
Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.6K

Related Experiment Videos

Last Updated: Apr 20, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

29.4K
AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain
09:59

AAV Deployment of Enhancer-Based Expression Constructs In Vivo in Mouse Brain

Published on: March 31, 2022

3.4K
Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.6K

Area of Science:

  • Genomics
  • Molecular Biology
  • Biotechnology

Background:

  • Genome editing in cell lines offers insights into biological processes and disease mechanisms.
  • Nuclease-based technologies (Zinc-Finger Nucleases, TALENS, Crispr/Cas9) utilize DNA repair pathways like non-homologous end-joining (NHEJ) and homology directed repair (HDR).
  • These methods enable various genetic modifications but can have limitations in precision and predictability.

Purpose of the Study:

  • To describe the generation and application of Adeno-Associated Virus (AAV) gene targeting vectors and viruses.
  • To highlight the creation of targeted isogenic cell lines using AAV technology.
  • To showcase the utility of AAV for precise genetic alterations.

Main Methods:

  • Utilizing Adeno-Associated Virus (AAV) for gene targeting.
  • Employing homologous recombination for precise genetic modifications at the target locus.
  • Developing AAV gene targeting vectors and viruses for cell line engineering.

Main Results:

  • Successfully generated over 500 human isogenic cell lines.
  • Created a wide range of genetic alterations including gene knockouts, point mutations, indels, epitope tags, and reporter genes.
  • Demonstrated the precision and predictability of AAV-mediated gene editing.

Conclusions:

  • AAV gene targeting is a powerful and versatile tool for creating precise isogenic cell lines.
  • This technology facilitates in-depth study of gene function and disease biology.
  • AAV-mediated homologous recombination offers a reliable method for complex genomic modifications.